Physician profile
Jeff Hetman
NPI 1326092081
$7,187.90
in general payments reported to CMS, 2019-2025
13 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $437 · 2021: $2,586 · 2022: $1,135 · 2023: $949 · 2024: $989 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Travel and Lodging: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.60 |
| Travel and Lodging | $373.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,541.69 | 2019-2025 | Augment Injectable, Prostep, Viaflow |
| Treace Medical Concepts, INC. | $2,756.12 | 2021-2025 | |
| Fusion Orthopedics USA, LLC | $264.68 | 2024 | |
| Trimed, INC. | $148.81 | 2022-2023 | |
| Bone Support INC. | $148.13 | 2024 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $118.41 | 2024 | Nushield |
| Alafair Biosciences, INC. | $70.88 | 2022-2023 | Versawrap |
| Zimmer Biomet Holdings, INC. | $28.54 | 2020 | |
| Horizon Therapeutics Plc | $28.38 | 2019 | |
| Depuy Synthes Sales INC. | $24.48 | 2019 | |
| Kerecis Limited | $22.14 | 2021 | |
| Celularity INC. | $17.87 | 2020 | |
| Medtronic, INC. | $17.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Hetman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.